Place of Death in Patients with Motor Neuron Disease and the Association with Comorbidities During the Coronavirus Disease 2019 Pandemic: A Population-Based Analysis

Key points

Investigates the comorbidities of COVID-19 with various motor neuron diseases.

Screenshot of the first two pages of a paper

Affiliates

Jaime Raymond, MPH1; Björn Oskarsson, MD2; Theodore Larson, MS1; Suraya Mohidul, MPH3; David Kevin Horton, DrPH, MSPH1; and Paul Mehta, MD1

  1. Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)/Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
  2. Mayo Clinic, Jacksonville, FL, USA
  3. Hite Consulting Inc., Atlanta, GA, USA

Journal

Journal of Palliative Care

Summary

Researchers investigated the impact of COVID-19 on place of death for MND (motor neuron disease) patients and comorbidities in the US. Study researchers analyzed 30,066 MND deaths, (14,562 pre-COVID-19 and 15,504 during COVID-19. They found that MND deaths at home increased during COVID-19.

Additionally, an increase in diabetes mellitus and essential hypertension was observed during COVID-19. The increase in at-home deaths suggests a need for improved home-based care services for MNDs. The increased comorbidities suggest the need for further preventative patient care research and comorbidities management during disasters.

Link to the Paper

Read the full paper here!

Print
Content Source:
Agency for Toxic Substances and Disease Registry